한국바이오의약품협회에서 안내드립니다.
<WHO VACCINE MANUFACTURING WORKSHOP FOR SOUTH-EAST ASIA AND THE WESTERN PACIFIC REGIONS>
A lesson learnt from the COVID-19 pandemic is the importance of having a geographically diversified vaccine production to meet the global and local demands and enhance vaccination uptake. I know that this is an important issue too for IVI and you are looking at supporting this. Equitable access to affordable and quality-assured vaccines continues to be at the forefront of initiatives encouraging vaccine manufacturers to actively partake the production of routine vaccines and increase their adaptability to new technologies. With this in mind we would be really excited if IVI could join an event we are planning to boost regional vaccine manufacturing capacity.
WHO is planning to conduct regional vaccine manufacturing workshop in collaboration with WHO headquarters, Regional Office for South-East Asia, Regional Office for the Western Pacific, Coalition for Epidemic Preparedness Innovations (CEPI), from 21-22 February, 15H00 – 17H30 (Philippine Standard Time; the exact time to be confirmed and informed to those who register as participant in advance). (한국시간 2022.2.21 ~2.22 / 14:00~16:30)
This event is first ever bringing government departments, vaccine regulators, vaccine manufacturers & associations, global and regional partners such as government department and NRAs BMGF, PATH, CEPI, WB, ADB, IVI and others in the region. This workshop will bring a platform to engage, dialogue and collaborate towards preparedness and response to COVID-19 and future pandemics and vaccines under routine immunization to improve vaccine security, in particular, in LMICs. It aims to address the specific needs at country and regional levels on the development plans for a robust and sustainable local production environment and to deliver thoughts and ideas on potential regional roadmaps in South-East Asia and Western Pacific regions to strengthen vaccine production capacity/capability and improve production efficiency through strategic WHO policies and guidelines, research and development, financial investment, political and government commitment.
The objectives of the meeting are to:
· Present and discuss the regional panorama of vaccine production capacity/capability as well as challenges and gaps in the South-East Asia and Western Pacific regions;
· Review and share CEPI’s 2021 vaccine manufacturing landscape survey data collected from the WHO South-East Asia and the Western Pacific regions;
· Explore the development of a regional roadmap towards improving vaccine manufacturing capacity/capability and/or efficiencies to improve epidemic/pandemic preparedness and response in the South-East Asia and the Western Pacific regions
Draft agenda is found below for your information. Updated version will be provided to those who register in advance. Here is the link for pre-registration.
Day 1: 21 Feb 2022 08:00 – 10:30 CET, 12:30 – 15:00 IST, 15:00 – 17:30 PHST Chair: Rogério Pinto De Sá Gaspar (WHO/HQ) |
Time | Topic | Speaker |
08:00 | Welcome and opening remarks (5 min each) | · Poonam Khetrapal Singh (WHO/SEARO) · Takeshi Kasai (WHO/ WPRO) · Mariângela Simão (WHO/HQ) · Soumya Swaminathan (WHO/HQ) · Richard Hatchett (CEPI) |
08:25 | Objectives of the regional vaccine manufacturing workshop (5 min) | · Jicui Dong (WHO/HQ) |
08:30 | Regional landscape, WHO policies and guidelines on vaccine R&D, production and access · South-East Asia region (15 min) · Western Pacific region (15 min) | · WHO/ SEARO · Socorro Escalante (tbc) (WHO/ WPRO) |
09:00 | Update on WHO activities for strengthening the local vaccine production: · WHO/HQ activities – Local Production and Assistance unit (15 min) | · Jicui Dong/ David Woo (WHO/HQ) |
09:15 | Introduce and review the CEPI 2021 vaccine manufacturing survey data identifying gaps/opportunities across South-East Asia and Western Pacific regions (30 min) | · Moderator: Matthew Downham (CEPI) |
09:45 | Brainstorm on future activities to support improving vaccine manufacture capacity/capability and/or efficiencies in South-East Asia and Western Pacific regions focusing on: (Breakout: 20 min, Main plenary: 15 min) · What are the requirements to address and mitigate identified vaccine manufacturing gaps and opportunities? · How to effectively improve vaccine manufacturing production and efficiencies in South-East Asia and Western Pacific including e.g. collaboration with member state government bodies? · What are the expectations of global stakeholders to support delivering the identified gaps/opportunities? | · Moderator: Matthew Downham (CEPI) |
10:20 | Day 1 wrap up (5 min each: WHO/SEARO & WHO/WPRO) | · WHO/SEARO · WHO/WPRO |
Day 2: 22 Feb 2022 08:00 – 10:30 CET, 12:30 – 15:00 IST, 15:00 – 17:30 PHST Chair: Suman Rijal (WHO/SEARO) & Martin Taylor (WHO/ WPRO) |
Time | Topic | Speaker |
08:00 | Welcome and introduction (5 min each) | · Suman Rijal (WHO/SEARO) · Martin Taylor (WHO/ WPRO) |
08:10 | Core features of a roadmap to establish and/or expand vaccine manufacturing capacity and capability · Scientific and technical considerations (10 min) · Business model and market considerations (10 min) · Infrastructure, regulatory systems, workforce and partnerships (10 min) | · Simone Blayer / Darin Zehrung (PATH) · David Robinson (B&M Gates) · Jicui Dong (WHO/HQ) |
08:40 | PART 1: PRESENTATION Plan towards improving vaccine development/ manufacturing capacity/capability and/or efficiencies in South-East Asia and Western Pacific regions · Governments o Government of Viet Nam (6 min) (tbc) o Government of Philippines (6 min) (tbc) o Government of Indonesia (6 min) (tbc) · Vaccine developer and manufacturers o Gennova Biopharmaceuticals, India (6 min) o Serum Institute of India Pvt. Ltd., India (6 min) o Siam Biosciences, Thailand (6 min) · Partners o Asian Development Bank (6 min) o International Vaccine Institute (6 min) (tbc) o Developing Countries Vaccine Manufacturers Network (DCVMN) (6 min) | · Member states · Vaccine developer and manufacturers · Partners Moderator: WHO/SEARO & WHO/WPRO |
09:35 | PART 2: MODERATED DISCUSSION · How local vaccine manufacturing can address vaccine access gaps in Asia (10 min) · What are the requirements to further improve vaccine manufacturing in South-East Asia and Western Pacific regions? (20 min) o Upgrade and/ or expand existing vaccine manufacturing capacity and capabilities o Implement new, innovative technologies and if so which o Establish collaborations, partnerships, associations and coordination with region and/ or global stakeholders | · Joshua Chu (CHAI) · Moderator: Matthew Downham (CEPI) |
10:05 | Day 2 wrap up, conclusion and next steps (20 min) | · Jicui Dong (WHO/HQ) |
> 알림마당 > 공지사항
오시는 길
로그인
회원가입